Andreas Sellmer

1.4k total citations
35 papers, 1.1k citations indexed

About

Andreas Sellmer is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Andreas Sellmer has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 15 papers in Organic Chemistry and 12 papers in Oncology. Recurrent topics in Andreas Sellmer's work include Histone Deacetylase Inhibitors Research (16 papers), Peptidase Inhibition and Analysis (9 papers) and Bioactive Compounds and Antitumor Agents (6 papers). Andreas Sellmer is often cited by papers focused on Histone Deacetylase Inhibitors Research (16 papers), Peptidase Inhibition and Analysis (9 papers) and Bioactive Compounds and Antitumor Agents (6 papers). Andreas Sellmer collaborates with scholars based in Germany, Austria and Egypt. Andreas Sellmer's co-authors include Siavosh Mahboobi, Oliver H. Krämer, Emerich Eichhorn, Herwig Pongratz, Thomas Beckers, Thomas M. Maier, Stefan Dove, Thomas Ciossek, Sigurd Elz and Mathias Winkler and has published in prestigious journals such as Oncogene, Journal of Medicinal Chemistry and Trends in Pharmacological Sciences.

In The Last Decade

Andreas Sellmer

35 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Sellmer Germany 20 711 471 277 101 72 35 1.1k
Yoshihiko Kotake Japan 14 1.1k 1.6× 481 1.0× 181 0.7× 89 0.9× 124 1.7× 22 1.5k
Stacy Remiszewski United States 18 910 1.3× 341 0.7× 211 0.8× 160 1.6× 107 1.5× 24 1.2k
Siavosh Mahboobi Germany 26 1.0k 1.5× 858 1.8× 369 1.3× 183 1.8× 113 1.6× 76 1.8k
Radek Jorda Czechia 22 637 0.9× 541 1.1× 352 1.3× 102 1.0× 68 0.9× 75 1.2k
Juiwanna Kushner United States 22 697 1.0× 389 0.8× 140 0.5× 228 2.3× 54 0.8× 31 1.1k
Ernesto Menta Italy 17 616 0.9× 543 1.2× 304 1.1× 74 0.7× 81 1.1× 36 1.1k
Michael K. Schwaebe United States 13 1.4k 1.9× 290 0.6× 294 1.1× 47 0.5× 43 0.6× 21 1.7k
Brendan Frett United States 20 493 0.7× 531 1.1× 190 0.7× 53 0.5× 36 0.5× 53 1.0k
Zuping Xia United States 14 694 1.0× 320 0.7× 253 0.9× 70 0.7× 52 0.7× 30 1.1k
Jeremy L. Yap United States 16 727 1.0× 256 0.5× 183 0.7× 93 0.9× 21 0.3× 22 867

Countries citing papers authored by Andreas Sellmer

Since Specialization
Citations

This map shows the geographic impact of Andreas Sellmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Sellmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Sellmer more than expected).

Fields of papers citing papers by Andreas Sellmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Sellmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Sellmer. The network helps show where Andreas Sellmer may publish in the future.

Co-authorship network of co-authors of Andreas Sellmer

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Sellmer. A scholar is included among the top collaborators of Andreas Sellmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Sellmer. Andreas Sellmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sellmer, Andreas, Karsten Spiekermann, Maria Reinecke, et al.. (2025). Novel water-soluble and highly efficient dual type I/II next generation inhibitors of FMS-like tyrosine kinase 3 (FLT3). European Journal of Medicinal Chemistry. 296. 117849–117849. 2 indexed citations
2.
Beyer, Mandy, Andrea Piée‐Staffa, Andreas Sellmer, et al.. (2021). Inhibitors of class I HDACs and of FLT3 combine synergistically against leukemia cells with mutant FLT3. Archives of Toxicology. 96(1). 177–193. 19 indexed citations
3.
Beyer, Mandy, Markus Christmann, Andreas Sellmer, et al.. (2021). Identification of a highly efficient dual type I/II FMS-like tyrosine kinase inhibitor that disrupts the growth of leukemic cells. Cell chemical biology. 29(3). 398–411.e4. 18 indexed citations
4.
Sellmer, Andreas, Mandy Beyer, Herwig Pongratz, et al.. (2020). A series of novel aryl-methanone derivatives as inhibitors of FMS-like tyrosine kinase 3 (FLT3) in FLT3-ITD-positive acute myeloid leukemia. European Journal of Medicinal Chemistry. 193. 112232–112232. 14 indexed citations
5.
Beyer, Mandy, A Romański, Andrea Pautz, et al.. (2019). HDAC3 Activity is Essential for Human Leukemic Cell Growth and the Expression of β-catenin, MYC, and WT1. Cancers. 11(10). 1436–1436. 28 indexed citations
6.
Sellmer, Andreas, Oliver H. Krämer, Stefan Dove, et al.. (2018). Design and biological evaluation of tetrahydro-β-carboline derivatives as highly potent histone deacetylase 6 (HDAC6) inhibitors. European Journal of Medicinal Chemistry. 152. 329–357. 36 indexed citations
7.
Borisova, Marina E., Sigrid Reichardt, Maren Godmann, et al.. (2017). HSP90 is necessary for the ACK1-dependent phosphorylation of STAT1 and STAT3. Cellular Signalling. 39. 9–17. 31 indexed citations
8.
Mahboobi, Siavosh, et al.. (2016). Generation and Assessment of Fusions Between HDACi and TKi. Methods in molecular biology. 1510. 405–412. 6 indexed citations
9.
Wirth, Matthias, Patrick Wenzel, Mandy Beyer, et al.. (2016). HDAC1 and HDAC2 integrate the expression of p53 mutants in pancreatic cancer. Oncogene. 36(13). 1804–1815. 87 indexed citations
10.
Grebien, Florian, Dagmar Hildebrand, Markus Christmann, et al.. (2016). Analysis of the interplay between all-trans retinoic acid and histone deacetylase inhibitors in leukemic cells. Archives of Toxicology. 91(5). 2191–2208. 25 indexed citations
11.
Schäfer, Claudia, Mandy Beyer, Nicole Kiweler, et al.. (2016). Class I histone deacetylases regulate p53/NF-κB crosstalk in cancer cells. Cellular Signalling. 29. 218–225. 42 indexed citations
12.
Krämer, Oliver H., Siavosh Mahboobi, & Andreas Sellmer. (2014). Drugging the HDAC6–HSP90 interplay in malignant cells. Trends in Pharmacological Sciences. 35(10). 501–509. 113 indexed citations
13.
Beckers, Thomas, Andreas Sellmer, Emerich Eichhorn, et al.. (2011). Novel inhibitors of epidermal growth factor receptor: (4-(Arylamino)-7H-pyrrolo[2,3-d]pyrimidin-6-yl)(1H-indol-2-yl)methanones and (1H-indol-2-yl)(4-(phenylamino)thieno[2,3-d]pyrimidin-6-yl)methanones. Bioorganic & Medicinal Chemistry. 20(1). 125–136. 27 indexed citations
14.
15.
Mahboobi, Siavosh, Emerich Eichhorn, Mathias Winkler, Andreas Sellmer, & Ute Möllmann. (2007). Antibacterial activity of a novel series of 3-bromo-4-(1H-3-indolyl)-2,5-dihydro-1H-2,5-pyrroledione derivatives – An extended structure–activity relationship study. European Journal of Medicinal Chemistry. 43(3). 633–656. 15 indexed citations
16.
17.
Mahboobi, Siavosh, Andrea Uecker, Andreas Sellmer, et al.. (2006). Inhibition of FLT3 and PDGFR tyrosine kinase activity by bis(benzo[b]furan-2-yl)methanones. Bioorganic & Medicinal Chemistry. 15(5). 2187–2197. 25 indexed citations
18.
Mahboobi, Siavosh, et al.. (2006). 3-Bromo-4-(1H-3-indolyl)-2,5-dihydro-1H-2,5-pyrroledione derivatives as new lead compounds for antibacterially active substances. European Journal of Medicinal Chemistry. 41(2). 176–191. 43 indexed citations
19.
Mahboobi, Siavosh, Andreas Sellmer, Emerich Eichhorn, et al.. (2006). [4-(Imidazol-1-yl)thiazol-2-yl]phenylamines. A Novel Class of Highly Potent Colchicine Site Binding Tubulin Inhibitors: Synthesis and Cytotoxic Activity on Selected Human Cancer Cell Lines. Journal of Medicinal Chemistry. 49(19). 5769–5776. 24 indexed citations
20.
Mahboobi, Siavosh, Andreas Sellmer, Emerich Eichhorn, et al.. (2004). Synthesis and cytotoxic activity of 2-acyl-1H-indole-4,7-diones on human cancer cell lines. European Journal of Medicinal Chemistry. 40(1). 85–92. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshihiko Kotake Breakdown of academic impact, for papers by Stacy Remiszewski Breakdown of academic impact, for papers by Siavosh Mahboobi Breakdown of academic impact, for papers by Radek Jorda Breakdown of academic impact, for papers by Juiwanna Kushner Breakdown of academic impact, for papers by Ernesto Menta Breakdown of academic impact, for papers by Michael K. Schwaebe Breakdown of academic impact, for papers by Brendan Frett Breakdown of academic impact, for papers by Zuping Xia Breakdown of academic impact, for papers by Jeremy L. Yap
Rankless by CCL
2026